InvestSMART

Emyria Limited (ASX: EMD) - Announcements

Current share price for EMD : $0.050 0.001 (2.04%)+

ASX company news and announcements for Emyria Limited (EMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emyria Limited (EMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emyria Limited (EMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emyria Limited (EMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$40 Emyria Presentation at FDA Hearing 16 Sep 2026 9:15AM $0.052 $0.050 fallen by 3.85%
$40 FDA Selects EMD to Present at Psychedelic Medicines Hearing 10 Sep 2026 9:35AM $0.048 $0.050 risen by 4.17%
$40 Emyria Set to Launch First NSW Clinic 8 Sep 2026 8:23AM $0.046 $0.050 risen by 8.70%
$40 Emyria Year End Presentation for Investor Webinar 8 Sep 2026 8:13AM $0.046 $0.050 risen by 8.70%
$40 Emyria Financial Year-end Update Webinar 7 Sep 2026 9:05AM $0.044 $0.050 risen by 13.64%
$40 Revised Securities Trading Policy 7 Sep 2026 9:03AM $0.044 $0.050 risen by 13.64%
$40 Appendix 4E & Annual Financial Report Year End 30 June 2026 31 Aug 2026 6:38PM $0.045 $0.050 risen by 11.11%
$40 2026 Annual General Meeting - Key Dates 31 Aug 2026 6:20PM $0.045 $0.050 risen by 11.11%
$40 Emyria Unlocks Treatment Capacity 20 Aug 2026 9:11AM $0.044 $0.050 risen by 13.64%
$40 Notification of cessation of securities - EMD 17 Aug 2026 8:05AM $0.047 $0.050 risen by 6.38%
$40 Change of Registered Office and Principal Place of Business 10 Aug 2026 9:57AM $0.047 $0.050 risen by 6.38%
$40 June 2026 Quarterly Activities Report and Appendix 4C 29 Jul 2026 9:10AM $0.048 $0.050 risen by 4.17%
$40 June 2026 Quarterly Investor Webinar 29 Jul 2026 9:06AM $0.048 $0.050 risen by 4.17%
$40 Techknow Invest Roadshow Company Presentation 27 Jul 2026 9:25AM $0.044 $0.050 risen by 13.64%
$40 EMD to Present at Addressing the Mental Health Crisis Event 22 Jul 2026 8:41AM $0.047 $0.050 risen by 6.38%
$40 Emyria to Present at Upcoming Investor and Industry Events 16 Jul 2026 9:42AM $0.041 $0.050 risen by 21.95%
$40 Emyria Depression Program Shows Positive Results 24 Jun 2026 9:35AM $0.039 $0.050 risen by 28.21%
$40 Emyria Confirms NSW Workforce Ahead of Clinic Opening 22 Jun 2026 9:17AM $0.038 $0.050 risen by 31.58%
$40 Emyria Company Update - Video Presentation 16 Jun 2026 9:42AM $0.041 $0.050 risen by 21.95%
$40 Emyria Company Update Presentation 11 Jun 2026 9:10AM $0.040 $0.050 risen by 25%
$40 Notification of cessation of securities - EMD 9 Jun 2026 8:17AM $0.043 $0.050 risen by 16.28%
$40 Change of Director's Interest Notice x 2 29 May 2026 6:32PM $0.049 $0.050 risen by 2.04%
$40 Notification regarding unquoted securities - EMD 29 May 2026 6:30PM $0.049 $0.050 risen by 2.04%
$40 Application for quotation of securities - EMD 29 May 2026 6:24PM $0.049 $0.050 risen by 2.04%
$40 TGA Update to Accelerate Empax Therapist Recruitment 28 May 2026 9:46AM $0.040 $0.050 risen by 25%

1 - 25 of 563 results

Page 1 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.